Bone Morphogenetic Protein: The State of the Evidence for On-Label and Off-Label Use

Disposition of Comments

Comments received from draft review on Bone Morphogenetic Protein: The State of the Evidence for On-Label and Off-Label Use.

Disposition of Comments

Project ID: BMPE0109


The Agency for Healthcare Research and Quality's (AHRQ) Technology Assessment (TA) Program supports and is committed to the transparency of its review process. Therefore, invited peer review comments and public review comments are publicly posted on the TA Program Web site at http://www.ahrq.gov/clinic/techix.htm within 3 months after the associated final report is posted.

This document presents the peer review comments and public review comments sent in response to the draft report, Bone Morphogenetic Protein: The State of the Evidence for On-Label and Off-Label Use, which was made available for comment on the AHRQ Web site. The final version of the report is available online.


 

Contents

Select for Table 1: Invited Peer Reviewer Comments
Select for Table 2: Public Review Comments
Select for Print version (PDF file, 192 KB). Plugin Software Help.

Page last reviewed September 2012
Internet Citation: Bone Morphogenetic Protein: The State of the Evidence for On-Label and Off-Label Use: Disposition of Comments. September 2012. Agency for Healthcare Research and Quality, Rockville, MD. http://www.ahrq.gov/research/findings/ta/comments/boneprotein.html